SCHEMBL2470237

SCHEMBL2470237

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@](O)(OP(=O)(S)OC(O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H]1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNASEL Q05823 4/20 0.53
P2RY2 P41231 2/20 0.47
FHIT P49789 3/20 0.42
ADORA1 P30542 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
DPP4 P27487 1/20 0.42
MEN1 O00255 1/20 0.42
SLC28A1 O00337 1/20 0.42
MAP3K7 O43318 1/20 0.42
SLC28A2 O43868 1/20 0.42
GAPDH P04406 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
MAPK1 P28482 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
STAT6 P42226 1/20 0.42
PI4KA P42356 1/20 0.42
KMT2A Q03164 1/20 0.42
PI4K2B Q8TCG2 1/20 0.42
DOT1L Q8TEK3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470251 0.91 RNASEL (0.51) RNASELP2RY2FHITADORA1SMN1; SMN2
SCHEMBL2470239 0.91 RNASEL (0.51) RNASELP2RY2FHITADORA1SMN1; SMN2
SCHEMBL2470248 0.91 RNASEL (0.51) RNASELP2RY2FHITADORA1SMN1; SMN2
SCHEMBL16495067 0.82 SLC28A1 (0.45) P2RY2SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL18259721 0.79 P2RY12 (0.41) RNASELP2RY2ADORA1ADORA3ADORA2A
SCHEMBL18259722 0.79 P2RY12 (0.41) RNASELP2RY2ADORA1ADORA3ADORA2A
SCHEMBL7150959 0.77 RNASEL (0.60) RNASELP2RY2ADORA1SMN1; SMN2DNPH1
SCHEMBL29403525 0.76 RNASEL (0.67) RNASELP2RY2ADORA1SMN1; SMN2DNPH1
Adenosine SCHEMBL8351411 0.76 ADORA3 (0.74) RNASELP2RY2ADORA1SMN1; SMN2DPP4
Adenosine SCHEMBL2248919 0.76 ADORA3 (0.74) RNASELP2RY2ADORA1SMN1; SMN2DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370451-A2 METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS Chiralgen, Ltd. (JP) 2011-10-05 EP disclosed
WO-2010064146-A2 METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS CHIRALGEN, LTD. (JP) 2010-06-10 WO disclosed